Exforge HCT

Exforge HCT is owned by Novartis AG, headquartered in Switzerland. No. The ultimate owner of Exforge HCT, Novartis AG, is headquartered in Switzerland, not in the United States.

Novartis is a Swiss multinational pharmaceutical corporation and one of the largest pharmaceutical companies in the world by market cap and sales.

Novartis Farmacéutica, S.A. (Spain)